SeqLL Equity Warrant Exp 6th Aug 2026 SQLLW:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/30/22 EDT
0.0861UNCH (UNCH)
Volume
7,075
52 week range
0.05 - 1.42
Loading...
  • Open0.0511
  • Day High0.0861
  • Day Low0.051
  • Prev Close0.0861
  • 52 Week High1.42
  • 52 Week High Date11/02/21
  • 52 Week Low0.05
  • 52 Week Low Date05/23/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.0511
  • Day High0.0861
  • Day Low0.051
  • Prev Close0.0861
  • 52 Week High1.42
  • 52 Week High Date11/02/21
  • 52 Week Low0.05
  • 52 Week Low Date05/23/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SeqLL Equity Warrant Exp 6th Aug 2026

 

Profile

MORE
SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. It offers ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sequencing solutions. It uses its true single molecule sequencing (tSMS) technology. SeqLL offers RNA and specialty DNA sequencing services utilizing tSMS. SeqLL offers a range of RNA sequencing services, including its...
Daniel Jones
President, Chief Executive Officer, Co-Founder, Director
John Kennedy
Chief Financial Officer
Address
317 New Boston St Ste 210
Woburn, MA
01801-6231
United States